| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 15 |
| 1 | MYCOPHENOLATE MOFETIL | 2 |
| 2 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 2 |
| 3 | PREDNISONE | 2 |
| 4 | RITUXIMAB | 2 |
| 5 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 |
| 6 | ALPRAZOLAM | 1 |
| 7 | ANTI ITCH | 1 |
| 8 | ANTI-ITCH | 1 |
| 9 | ANTI-ITCH CREAM | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OCRELIZUMAB AND HYALURONIDASE | 1 | 0.0020 |
| 1 | UBLITUXIMAB | 1 | 0.0003 |
| 2 | OCRELIZUMAB | 15 | 0.0002 |
| 3 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 4 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| 5 | ESZOPICLONE | 1 | 0.0000 |
| 6 | DEXLANSOPRAZOLE | 1 | 0.0000 |
| 7 | COPPER | 1 | 0.0000 |
| 8 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 | 0.0000 |
| 9 | ANTI-ITCH CREAM | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 18 | 0.0001 |
| 2 | Copper-containing Intrauterine Device [EPC] | 1 | 0.0000 |
| 3 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Estrogen [EPC] | 1 | 0.0000 |
| 6 | Benzodiazepine [EPC] | 3 | 0.0000 |
| 7 | Corticosteroid [EPC] | 3 | 0.0000 |
| 8 | Proton Pump Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 1 | 0.0000 |